These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23519759)

  • 1. Stem cell-derived cardiomyocytes as a tool for studying proarrhythmia: a better canary in the coal mine?
    Roden DM; Hong CC
    Circulation; 2013 Apr; 127(16):1641-3. PubMed ID: 23519759
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity.
    Liang P; Lan F; Lee AS; Gong T; Sanchez-Freire V; Wang Y; Diecke S; Sallam K; Knowles JW; Wang PJ; Nguyen PK; Bers DM; Robbins RC; Wu JC
    Circulation; 2013 Apr; 127(16):1677-91. PubMed ID: 23519760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Finding the rhythm of sudden cardiac death: new opportunities using induced pluripotent stem cell-derived cardiomyocytes.
    Sallam K; Li Y; Sager PT; Houser SR; Wu JC
    Circ Res; 2015 Jun; 116(12):1989-2004. PubMed ID: 26044252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular genetics of arrhythmias and cardiovascular conditions associated with arrhythmias.
    Antzelevitch C
    J Cardiovasc Electrophysiol; 2003 Nov; 14(11):1259-72. PubMed ID: 14678150
    [No Abstract]   [Full Text] [Related]  

  • 5. Use and interpretation of genetic tests in cardiovascular genetics.
    Caleshu C; Day S; Rehm HL; Baxter S
    Heart; 2010 Oct; 96(20):1669-75. PubMed ID: 20937756
    [No Abstract]   [Full Text] [Related]  

  • 6. Modelling the long QT syndrome with induced pluripotent stem cells.
    Itzhaki I; Maizels L; Huber I; Zwi-Dantsis L; Caspi O; Winterstern A; Feldman O; Gepstein A; Arbel G; Hammerman H; Boulos M; Gepstein L
    Nature; 2011 Mar; 471(7337):225-9. PubMed ID: 21240260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interpretation of field potentials measured on a multi electrode array in pharmacological toxicity screening on primary and human pluripotent stem cell-derived cardiomyocytes.
    Tertoolen LGJ; Braam SR; van Meer BJ; Passier R; Mummery CL
    Biochem Biophys Res Commun; 2018 Mar; 497(4):1135-1141. PubMed ID: 28153730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of extracellular field potential and Ca
    Abi-Gerges N; Pointon A; Oldman KL; Brown MR; Pilling MA; Sefton CE; Garside H; Pollard CE
    J Pharmacol Toxicol Methods; 2017; 83():1-15. PubMed ID: 27622857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Batch Variations in Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes from 2 Major Suppliers.
    Huo J; Kamalakar A; Yang X; Word B; Stockbridge N; Lyn-Cook B; Pang L
    Toxicol Sci; 2017 Mar; 156(1):25-38. PubMed ID: 28031415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSAHi study: Evaluation of multi-electrode array in combination with human iPS cell-derived cardiomyocytes to predict drug-induced QT prolongation and arrhythmia--effects of 7 reference compounds at 10 facilities.
    Kitaguchi T; Moriyama Y; Taniguchi T; Ojima A; Ando H; Uda T; Otabe K; Oguchi M; Shimizu S; Saito H; Morita M; Toratani A; Asayama M; Yamamoto W; Matsumoto E; Saji D; Ohnaka H; Tanaka K; Washio I; Miyamoto N
    J Pharmacol Toxicol Methods; 2016; 78():93-102. PubMed ID: 26657830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome.
    Yazawa M; Hsueh B; Jia X; Pasca AM; Bernstein JA; Hallmayer J; Dolmetsch RE
    Nature; 2011 Mar; 471(7337):230-4. PubMed ID: 21307850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thorough QT/QTc in a Dish: An In Vitro Human Model That Accurately Predicts Clinical Concentration-QTc Relationships.
    Blanchette AD; Grimm FA; Dalaijamts C; Hsieh NH; Ferguson K; Luo YS; Rusyn I; Chiu WA
    Clin Pharmacol Ther; 2019 May; 105(5):1175-1186. PubMed ID: 30346629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human-induced pluripotent stem cell models of inherited cardiomyopathies.
    Karakikes I; Termglinchan V; Wu JC
    Curr Opin Cardiol; 2014 May; 29(3):214-9. PubMed ID: 24576884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling long-QT syndromes with iPS cells.
    Sinnecker D; Goedel A; Dorn T; Dirschinger RJ; Moretti A; Laugwitz KL
    J Cardiovasc Transl Res; 2013 Feb; 6(1):31-6. PubMed ID: 23076501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cells for drug screening.
    Laposa RR
    J Cardiovasc Pharmacol; 2011 Sep; 58(3):240-5. PubMed ID: 21499120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induced pluripotent stem cell-derived cardiomyocytes: a versatile tool for arrhythmia research.
    Sinnecker D; Goedel A; Laugwitz KL; Moretti A
    Circ Res; 2013 Mar; 112(6):961-8. PubMed ID: 23569105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation.
    Matsa E; Rajamohan D; Dick E; Young L; Mellor I; Staniforth A; Denning C
    Eur Heart J; 2011 Apr; 32(8):952-62. PubMed ID: 21367833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Tension-Based Model Distinguishes Hypertrophic versus Dilated Cardiomyopathy.
    Davis J; Davis LC; Correll RN; Makarewich CA; Schwanekamp JA; Moussavi-Harami F; Wang D; York AJ; Wu H; Houser SR; Seidman CE; Seidman JG; Regnier M; Metzger JM; Wu JC; Molkentin JD
    Cell; 2016 May; 165(5):1147-1159. PubMed ID: 27114035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CSAHi study: Detection of drug-induced ion channel/receptor responses, QT prolongation, and arrhythmia using multi-electrode arrays in combination with human induced pluripotent stem cell-derived cardiomyocytes.
    Kitaguchi T; Moriyama Y; Taniguchi T; Maeda S; Ando H; Uda T; Otabe K; Oguchi M; Shimizu S; Saito H; Toratani A; Asayama M; Yamamoto W; Matsumoto E; Saji D; Ohnaka H; Miyamoto N
    J Pharmacol Toxicol Methods; 2017; 85():73-81. PubMed ID: 28163191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An electrifying iPSC disease model: long QT syndrome type 2 and heart cells in a dish.
    Kamp TJ
    Cell Stem Cell; 2011 Feb; 8(2):130-1. PubMed ID: 21295269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.